GKS Seeks Preemption Summary Judgment In 2-Month-Old Zofran MDL
Mealey's (December 21, 2015, 12:20 PM EST) -- BOSTON — Less than two months after the Zofran multidistrict litigation was created, GlaxoSmithKline LLC (GSK) on Dec. 11 filed a motion for summary judgment or dismissal on the grounds that...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login